Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Gilead Sciences key operating metrics including Countries, environmental, and social and governance score (ESG).

Countries

35

FY, 2021

Products

21
5.0%

FY, 2021

Phase II Trials Products (Viral Diseases)

1
66.7%

FY, 2021

Operating Metrics

MetricsFY, 2019FY, 2020FY, 2021
Countries353535
Products242021
Phase II Trials Products (Viral Diseases)231
Phase I Trials Products (Viral Diseases)3
Phase III Trials Products (Inflammatory and Fibrotic Diseases)322
Phase II Trials Products (Inflammatory and Fibrotic Diseases)7
Phase I Trials Products (Inflammatory and Fibrotic Diseases)4
Phase III Trials Products (Oncology)134
Phase II Trials Products (Oncology)231
Phase I Trials Products (Oncology)7
Clinical Trials104
Phase III Trials Products2789
Phase III Trial Products (Viral Diseases)33

Environmental, Social and Governance (ESG)

Overall

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu